Meta-analysis of factors related to health services that predict treatment default by tuberculosis patients

Cadernos de Saude Publica

Volumn 24, Issue SUPPL.4, 2008, Pages

  Do Brasil, Pedro Emmanuel Alvarenga Americano ^a,b   Braga, José Ueleres ^b,c  

^a Funda??o Oswaldo Cruz   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Centro de Referencia Professor Helio Fraga   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDEMIOLOGY; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HOSPITALIZATION; HUMAN; MALE; META ANALYSIS; PATIENT; PATIENT COMPLIANCE; REVIEW; RISK FACTOR; STATISTICS; TUBERCULOSIS;

BIAS (EPIDEMIOLOGY); EPIDEMIOLOGIC STUDIES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HOSPITALIZATION; HUMANS; MALE; PATIENT COMPLIANCE; PATIENT DROPOUTS; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE; RISK FACTORS; STATISTICS AS TOPIC; TUBERCULOSIS;

EID: 52949133716     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. World Health Organization. Global tuberculosis control: surveillance, planning, financing. Geneva: World Health Organization; 2005.
2. Comitê Assessor para Co-infecção HIV-Tuberculose, Comitê Técnico-Científico de Assessoramento à Tuberculose, Fundação Nacional de Saúde. Tuberculose: guia de vigilância epidemiológica. Brasília: Ministério da Saúde; 2002.
3. Malotte CK, Hollingshead JR, Larro M. Incentives vs. outreach workers for latent tuberculosis treatment in drug users. Am J Prev Med 2001; 20:103-7.
4. Demissie M, Kebede D. Defaulting from tuberculosis treatment at the Addis Abeba Tuberculosis Centre and factors associated with it. Ethiop Med J 1994; 32:97-106.
5. White MC, Tulsky J P, Reilly P, McIntosh HW, Hoynes TM, Goldenson J. A clinical trial of a financial incentive to go to the tuberculosis clinic for isoniazid after release from jail. Int J Tuberc Lung Dis 1998; 2:506-12.
6. Tulsky JP, Pilote L, Hahn JA, Zolopa AJ, Burke M, Chesney M, et al. Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial. Arch Intern Med 2000; 160:697-702.
7. Matteelli A, Casalini C, Raviglione MC, El-Hamad I, Scolari C, Bombana E, et al. Supervised preventive therapy for latent tuberculosis infection in illegal immigrants in Italy. Am J Respir Crit Care Med 2000; 162:1653-5.
8. Chaulet P. Compliance with anti-tuberculosis chemotherapy in developing countries. Tubercle 1987; 68(2 Suppl):19-24.
9. Natal S, Valente J, Gerhardt G, Pena ML. Modelo para prediçã o para o abandono do tratamento de tuberculose pulmonar. Bol Pneumol Sanit 1999; 7:66-78.
10. Volmink J, Garner P. Systematic review of randomised controlled trials of strategies to promote adherence to tuberculosis treatment. BMJ 1997; 315:1403-6.
11. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 2003; (1):CD003343.
12. Giuffrida A, Torgerson DJ. Should we pay the patient? Review of financial incentives to enhance patient compliance. BMJ 1997; 315:703-7.
13. Macharia WM, Leon G, Rowe BH, Stephenson BJ, Haynes RB. An overview of interventions to improve compliance with appointment keeping for medical services. JAMA 1992; 267:1813-7.
14. Volmink J, Garner P. Interventions for promoting adherence to tuberculosis management. Cochrane Database Syst Rev 2000; (2):CD000010.
15. Healton CG, Messeri P. The effect of video interventions on improving knowledge and treatment compliance in the sexually transmitted disease clinic setting. Lesson for HIV health education. Sex Transm Dis 1993; 20:70-6.
16. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994; 271: 698-702.
17. Haynes RB, McKibbon KA, Wilczynski NL, Walter SD, Werre SR. Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey. BMJ 2005; 330:1179.
18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-88.
19. Egger M, Davey-Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-34.
20. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50:1088-101.
21. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21:1539-58.
22. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-60.
23. Knapp G, Hartung J. Improved tests for a random effects meta-regression with a single covariate. Stat Med 2003; 22:2693-710.
24. nd Ed. London: BMJ Books; 2001.
25. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283:2008-12.
26. World Health Organization. What is DOTS? http://www.wpro.who.int/sites/ stb/dots_definition.htm (accessed on 16/Sep/2006).
27. Dwyer T, Couper D, Walter SD. Sources of heterogeneity in the meta-analysis of observational studies: the example of SIDS and sleeping position. J Clin Epidemiol 2001; 54:440-7.
28. Greenland S. Invited commentary: a critical look at some popular meta-analytic methods. Am J Epidemiol 1994; 140:290-6.
29. Petitti DB. Of babies and bathwater. Am J Epidemiol 1994; 140:779-82.
30. Salles CL, Conde MB, Hofer C, Cunha AJ, Calcada AL, Menezes DF, et al. Defaulting from anti-tuberculosis treatment in a teaching hospital in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis 2004; 8:318-22.
31. Gasner MR, Maw KL, Feldman GE, Fujiwara PI, Frieden TR. The use of legal action in New York City to ensure treatment of tuberculosis. N Engl J Med 1999; 340:359-66.
32. Cassels A, Heineman E, LeClerq S, Gurung PK, Rahut CB. Tuberculosis case-finding in Eastern Nepal. Tubercle 1982; 63:175-85.
33. Armstrong RH, Pringle D. Compliance with anti-tuberculous chemotherapy in Harare City. Cent Afr J Med 1984; 30:144-8.
34. Buri PS, Vathesatogkit P, Charoenpan P, Kiatboonsri S, Buranaratchada S. A clinic model for a better tuberculosis treatment outcome and factors influencing compliance. J Med Assoc Thai 1985; 68: 356-60.
35. van der Werf TS, Dade GK, van der Mark TW. Patient compliance with tuberculosis treatment in Ghana: factors influencing adherence to therapy in a rural service programme. Tubercle 1990; 71:247-52.
36. Irurzun RN, Hasper I, Garcia LE. Retratamiento por tuberculosis, incumplimiento del tratamien-to anterior y su relación con el mismo. Rev Argent Tórax 1990; 51:17-30.
37. Chuah SY. Factors associated with poor patient compliance with antituberculosis therapy in North-west Perak, Malaysia. Tubercle 1991; 72:261-4.
38. Barnwell MD, Chitkara R, Lamberta F. Tuberculosis prevention project. J Natl Med Assoc 1992; 84:1014-8.
39. Oviawe O, Ojemudia E. The problem of non-attendance at a paediatric tuberculosis outpatient clinic. Ann Trop Paediatr 1993; 13:243-7.
40. Moralez EMM, Montes VS, Perez GC, Guerrero E V, Romero CE, Peña JE. Principales causas de abandono del tratamiento contra la tuberculosis pulmonar. Gac Méd Méx 1993; 129:57-62.
41. Pilote L, Tulsky JP, Zolopa AR, Hahn JA, Schecter G F, Moss AR. Tuberculosis prophylaxis in the homeless. A trial to improve adherence to referral. Arch Intern Med 1996; 156:161-5.
42. Dick J, Lombard C. Shared vision: a health education project designed to enhance adherence to anti-tuberculosis treatment. Int J Tuberc Lung Dis 1997; 1:181-6.
43. Comolet TM, Rakotomalala R, Rajaonarioa H. Factors determining compliance with tuberculosis treatment in an urban environment, Tamatave, Madagascar. Int J Tuberc Lung Dis 1998; 2:891-7.
44. Nuwaha F. Control of tuberculosis in Uganda: a tale of two districts. Int J Tuberc Lung Dis 1999; 3: 224-30.
45. Liefooghe R, Suetens C, Meulemans H, Moran MB, De Muynck A. A randomised trial of the impact of counselling on treatment adherence of tuberculosis patients in Sialkot, Pakistan. Int J Tuberc Lung Dis 1999; 3:1073-80.
46. Morrone N, Solha MS, Cruvinel MC, Morrono Junior N, Freire JAS, Barbosa ZLM. Tuberculose: tratamento supervisionado "versus" tratamento auto-administrado. J Pneumol 1999; 25:198-206.
47. Liam CK, Lim KH, Wong CM, Tang BG. Attitudes and knowledge of newly diagnosed tuberculosis patients regarding the disease, and factors affecting treatment compliance. Int J Tuberc Lung Dis 1999; 3:300-9.
48. Borgdorff MW, Veen J, Kalisvaart NA, Broekmans JF, Nagelkerke NJ. Defaulting from tuberculosis treatment in The Netherlands: rates, risk factors and trend in the period 1993-1997. Eur Respir J 2000; 16:209-13.
49. Al-Hajjaj MS, Al-Khatim IM. High rate of non-compliance with anti-tuberculosis treatment despite a retrieval system: a call for implementation of directly observed therapy in Saudi Arabia. Int J Tuberc Lung Dis 2000; 4:345-9.
50. Ribeiro SA, Amado VM, Camelier AA, Fernandes MMA, Schenkman S. Estudo caso-controle de indicadores de abandono em doentes com tuberculose. J Pneumol 2000; 26:291-6.
51. Piyaworawong S, Yanai H, Nedsuwan S, Akarasewi P, Moolphate S, Sawanpanyalert P. Tuberculosis preventative therapy as part of a care package for people living with HIV in a district of Thailand. AIDS 2001; 15:1739-41.
52. Chaisson RE, Barnes GL, Hackman J, Watkinson L, Kimbrough L, Metha S, et al. A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users. Am J Med 2001; 110:610-5.
53. Escobar AL, Coimbra Jr. CEA, Camacho LA, Portela MC. Tuberculose em populações indígenas de Rondônia, Amazônia, Brasil. Cad Saúde Pública 2001; 17:285-98.
54. Hoz KF, Fernández S, Ordobás M, Gomez P, Fernandéz M, Arce A. Cumplimiento del tratamiento antituberculoso en presos excarcelados en la comunidad de Madrid. Enferm Infecc Microbiol Clin 2001; 19:362-6.
55. Liefooghe R, Muynck AD. The dynamics of tuberculosis treatment adherence. J Pak Med Assoc 2001; 51:3-9.
56. Morisky DE, Malotte CK, Ebin V, Davidson P, Cabrera D, Trout PT, et al. Behavioral interventions for the control of tuberculosis among adolescents. Public Health Rep 2001; 116:568-74.
57. Naing NN, D'Este C, Isa AR, Salleh R, Bakar N, Mahmod MR. Factors contributing to poor compliance with anti-TB treatment among tuberculosis patients. Southeast Asian J Trop Med Public Health 2001; 32:369-82.
58. White MC, Tulsky J P, Goldenson J, Portillo CJ, Kawamura M, Menendez E. Randomized controlled trial of interventions to improve follow-up for latent tuberculosis infection after release from jail. Arch Intern Med 2002; 162:1044-50.
59. Rabahi MF, Rodrigues AB, Mello FQ, Almeida Netto JC, Kritski AL. Noncompliance with tuberculosis treatment by patients at a tuberculosis and AIDS reference hospital in midwestern Brazil. Braz J Infect Dis 2002; 6:63-73.
60. Tekle B, Mariam DH, Ali A. Defaulting from DOTS and its determinants in three districts of Arsi Zone in Ethiopia. Int J Tuberc Lung Dis 2002; 6:573-9.
61. O'Boyle SJ, Power JJ, Ibrahim MY, Watson J P. Factors affecting patient compliance with anti-tuberculosis chemotherapy using the directly observed treatment, short-course strategy (DOTS). Int J Tuberc Lung Dis 2002; 6:307-12.
62. Hovell MF, Sipan CL, Blumberg EJ, Hofstetter CR, Slymen D, Friedman L, et al. Increasing Latino adolescents' adherence to treatment for latent tuberculosis infection: a controlled trial. Am J Public Health 2003; 93:1871-7.
63. Nyirenda TE, Harries AD, Gausi F, van Gorkom J, Maher D, Floyd K, et al. Decentralisation of tuberculosis services in an urban setting, Lilongwe, Malawi. Int J Tuberc Lung Dis 2003; 7(9 Suppl 1): S21-8.
64. Buu TN, Lonnroth K, Quy HT. Initial defaulting in the National Tuberculosis Programme in Ho Chi Minh City, Vietnam: a survey of extent, reasons and alternative actions taken following default. Int J Tuberc Lung Dis 2003; 7:735-41.
65. El-Sony AI, Mustafa SA, Khamis AH, Enarson DA, Baraka OZ, Bjune G. The effect of decentralisation on tuberculosis services in three states of Sudan. Int J Tuberc Lung Dis 2003; 7:445-50.
66. Alvarez-Gordillo GDC, Alvarez-Gordillo J F, Dorantes-Jiménez JE. Estrategia educativa para incrementar el cumplimiento del régimen antituberculoso en Chiapas, México. Rev Panam Salud Pública 2003; 14:402-8.
67. Demissie M, Getahun H, Lindtjorn B. Community tuberculosis care through "TB clubs" in rural North Ethiopia. Soc Sci Med 2003; 56:2009-18.
68. Salami AK, Oluboyo PO. Management outcome of pulmonary tuberculosis: a nine year review in Ilorin. West Afr J Med 2003; 22:114-9.
69. Cayla JA, Caminero JA, Rey R, Lara N, Valles X, Galdos-Tanguis H. Current status of treatment completion and fatality among tuberculosis patients in Spain. Int J Tuberc Lung Dis 2004; 8:458-64.